RAB DIAGNOSTICS AS
Developing predictive biomarkers for optimizing Antibody-Drug Conjugate therapies.
Översikt
- Okänt
- Anställda
- 325t NOK
- Omsättning
- 2023
- Grundat
Nyckelbeslutsfattare
Anette Weyergang
CEO
Anne Mathilde Kvamme
Board Member
Rosanne Welcher
Advisory board member
Ole Dahlberg
Board Member
+5 fler kontakter i Funnelfeedr
Beskrivning
Rab Diagnostics is a specialized biotechnology company headquartered in Oslo, Norway, focusing on biomarker development specifically for oncology-focused Antibody-Drug Conjugates (ADCs). They leverage their proprietary RabCANCER platform and deep expertise in intracellular drug trafficking to genera...